期刊文献+

移形上皮与鳞状上皮来源的恶性肿瘤摄取^(18)F-FDG差异性的实验研究 被引量:3

Differential Uptake of ^(18)F-FDG in Transitional Epithelium and Squamous Epithelium-derived Malignant Tumors
原文传递
导出
摘要 [目的]探讨来自不同上皮来源的肿瘤组织葡萄糖代谢的差异,为临床PET/CT应用中如何判断上皮组织来源的恶性肿瘤葡萄糖摄取出现的假阳性和假阴性等问题提供理论依据。[方法]BALB/C裸鼠12只,随机分为2组,并且皮下分别接种膀胱癌EJ细胞和宫颈癌Hela细胞,1×106/0.2ml使其成瘤。行小动物PET扫描,取得葡萄糖标准化摄取值(SUV),测量SUVmax和SUVmean对肿瘤组织葡萄糖代谢进行评价。[结果]膀胱癌SUVmax:4.22±0.39,SUVmean:2.60±0.43;宫颈癌SUVmax:6.18±0.23,SUVmean:2.40±0.57。膀胱癌与宫颈癌的SUVmax值差异有统计学意义(t=-9.474,P<0.01),而SUVmean值无统计学差异。[结论]鳞状上皮来源的肿瘤葡萄糖摄取要高于移形上皮来源的。 [Purpose] To compare the difference of glucose metabolism of tumor tissue from two different epithelial origins,and to provide a theoretical basis for resolving false positive and false negative problem in PET/CT application.[Methods] Twelve BALB/C nude mice were randomly divided into two groups,subcutaneously inoculated with 1×10 6 /0.2ml of cervical cancer Hela cells and bladder cancer EJ cells respectively.Micro-PET was undertaken to obtain glucose standardized uptake values(SUV).SUV max and SUV mean were measured to assess glucose metabolism in tumor tissues.[Results] SUV max and SUV mean for cervical cancer were 6.18±0.23 and 2.40±0.57,respectively.SUV max and SUV mean for bladder cancer were 4.22 ±0.39 and 2.60 ±0.43,respectively.SUV max between bladder cancer and cervical cancer was statistically different(t=-9.474,P0.01),while SUV mean was not significantly different between them.[Conclusion] Squamous epithelium-derived malignant tumor such as cervical cancer has higher glucose metabolism than transitional epithelium-derived malignant tumor such as bladder cancer.
出处 《肿瘤学杂志》 CAS 2012年第10期729-733,共5页 Journal of Chinese Oncology
基金 国家重大科学仪器设备开发专项(2011YQ03011409) 国家自然科学基金(81071183)
关键词 小动物PET 移形上皮 鳞状细胞癌 上皮细胞 ~18F-FDG 标准化摄取值 动物模型 micro positron emission tomography(Micro-PET) transitional epithelium squamous cell carcinoma epithelial cell 2-[~18F]fluoro-2-deoxy-D-glucose(~18F-FDG) standardized uptake value(SUV) animal model
  • 相关文献

参考文献1

二级参考文献3

共引文献2

同被引文献42

  • 1王斌,崔书钟,唐云强,王嘉康,张相良,赵宏宇,王来奎.羟基喜树碱与白介素——2膀胱灌注预防膀胱癌复发的临床研究[J].国际医药卫生导报,2006,12(20):40-41. 被引量:2
  • 2谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:573.
  • 3王荣福.核医学[M].第2版.北京:北京大学医学出版社,2009.129-149.
  • 4Lu X, Wang RF. A concise review of current radiopharma- ceuticals in tumor angiogenesis imaging [J]. Curr Pharm Des, 2012,18(8): 1032-1040.
  • 5Pacini F,Castagna MG,Brilli L,et al. Thyroid cancer. ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol,2010,21 (Suppl 5) :v214-v219.
  • 6Edward M, Messing MD. Urothelial Tumors of the Urinary Tract. In: Walsh PC, Retik AB, Vaughan ED, et al. Campbell's Urology. Vol 3 .8th ed. Philadelphia: WB Saunders Company,2002 : 2732-2782.
  • 7Kaldor JM, Day NE, Kittelmann B, et al. Bladder tumors following chemotherapy and radiotherapy for ovarian cancer: A case control study[J]. Int J Cancer, 1995, 63(1): 1-6.
  • 8DeLair SM, White RW, Kurzrock EA. Secondary transitional cell carcinoma and nitrogen mustard treatment[J]. Urology, 2005, 65(6):1226-1227.
  • 9Shiota M, Yokomizo A, Takeuchi A, et al. Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgendeprivation therapy[J]. Oncotarget, 2015, 6(16): 14710-14719.
  • 10Quihy PM, Kerr GR.Bladder cancer following lowor high-dose pelvic irradiation[J]. Clin Radiol, 1987, 38(6):583-585.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部